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Abstract: 
The cell surface interaction between bacterial lipopolysaccharide (LPS), Toll-like receptor 4 
(TLR4) and MD-2 is central to bacterial sepsis syndromes and wound healing. We have shown 
that a generation (G) 3.5 polyamidoamine (PAMAM) dendrimer that was partially glycosylated 
with glucosamine inhibits TLR4-MD-2-LPS induced inflammation in a rabbit model of tissue 
scaring. However, it was a mixture of closely related chemical species because of the 
polydispersity of the starting PAMAM dendrimer. Generation 2 triazine dendrimers with single 
chemical entity material status are available at low cost and at the kilogram scale. PAMAM 
dendrimer can be synthetically grafted onto this triazine core dendrimer to make new triazine-
PAMAM hybrid dendrimers. This led us to examine whether molecular modeling methods could 
be used to identify the key structural design principles for a bioactive lead molecule that could be 
synthesized and biologically evaluated.  We describe our computer aided molecular studies of 
several dendrimer based constructs and the key design principles identified. Our approach should 
be more broadly applicable to the biologically focused, rational and accelerated design of 
molecules for other TLR receptors. They could be useful for treating infectious, inflammatory 
and malignant diseases. 
Keywords: 
molecular modeling · dendrimer · triazine · PAMAM · glucosamine · TLR4 · LPS · MD-2 · 
inflammation · cytokines. 
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1. Introduction:
Since their introduction in 1985 and subsequent commercial availability, PAMAM dendrimers 
have served as the major anchoring platform for the exploration of the properties and potential of 
dendrimers[1]. To this end, PAMAM dendrimers have already been successfully used for 
diagnostic, sensing, material science and catalysis based applications[2-5]. 
We have already shown that a partially glycosylated Generation (G) 3.5 PAMAM dendrimer 
blocked TLR4-MD-2-LPS mediated pro-inflammatory cytokine responses[6]. It inhibited TLR4 
mediated inflammation in a rabbit model of tissue scaring (Figure 1). The biologically relevant 
cell surface interaction blocked was between bacterial lipopolysaccharide (LPS), host Toll‐like 
receptor 4 (TLR4) and MD-2 [7,8]. Park et al. have recently defined the structural basis of the 
recognition of LPS by the TLR4-MD-2 complex[9]. In brief, the transport protein CD14 collects 
and delivers LPS to MD-2. The two phosphorylated glucosamines of the lipid A component of 
LPS bind to the charged entrance of MD-2’s hydrophobic cavity. The surface residues lining the 
entrance of MD-2’s pocket that have been shown to have a key role in the electrostatic binding 
of LPS are Arg90, Lys91, Ser118 and Lys122 [10]. This is followed by the lipid chains of LPS 
becoming buried in MD-2’s hydrophobic cavity. The activated TLR4‐MD-2‐LPS complex 
undergoes conformational changes and receptor dimerization, and this triggers intracellular 
signaling events[9]. It also initiates the pro‐inflammatory chemokine and cytokine cascade 
responsible for host innate immune responses to pathogens and to surgical tissue injury. 
Our recent molecular docking studies have shown that these partially glycosylated dendrimers 
with a hydrophilic surface bind to the entrance of MD-2’s hydrophobic cavity and prevent the 
*
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binding of LPS[11]. They form co-operative electrostatic interactions with residues lining the 
entrance to MD-2’s hydrophobic pocket (Figure 2). Crucially, dendrimer glucosamine interferes 
with the electrostatic binding of: (i) the 4’phosphate on the di-glucosamine of LPS to Ser118 on 
MD-2; (ii) LPS to Lys91 on MD-2; (iii) the subsequent binding of TLR4 to Tyr102 on MD-2. 
This is followed by additional co-operative interactions between several of the dendrimer 
glucosamine’s carboxylic acid branches and MD-2.  Collectively, these interactions block the 
entry of the lipid chains of LPS into MD-2’s hydrophobic pocket and prevent TLR4-MD-2-LPS 
complex formation[11]. These partially glycosylated dendrimers did not interact with MD-2’s 
hydrophobic pocket, a property of other MD-2 antagonists such as eritoran.  
However, our active molecule 1 was a mixture of closely related chemical species. The largest 
contributor to this dispersity was the starting PAMAM material itself[1,12]. The availability of 
G2 triazine dendrimers at the kilogram scale and at low cost led us to investigate whether they 
could be used as an alternative starting dendrimer platform. These core materials are chemically 
well defined structures when compared to PAMAM core dendrimers[13]. For example, a 
comparative analysis with PAMAM analogues using capillary electrophoresis showed a 
significant difference in molecular heterogeneity; PAMAM dendrimers were mixtures of closely 
related molecules whereas triazine dendrimers approached single chemical entity material 
status[14,15]. 
Our initial synthetic studies of the partial glycosylation of G2 and G3 triazine dendrimers did not 
result in the reconstitution of the biological activity required (data not shown) despite these 
materials being of a size and having a surface glucosamine loading that was similar to the 
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biologically active PAMAM dendrimer glucosamine 1. As our previous modeling 
studies[11,16,17] had clearly demonstrated that the surface properties of partially glycosylated 
dendrimers determined their bioactivity (i.e., flexibility, cluster density, surface electrostatic 
charge and hydrophilicity), we went on to investigate whether grafting a biologically inactive, 
but single entity triazine dendrimer with a minimum number of PAMAM layers could lead to 
molecules that replicated the flexibility, cluster density, surface electrostatic charge, 
hydrophilicity and biological activity of 1. 
2. Materials and Methods
2.1. Molecular dynamics simulations: 
The minimization and molecular dynamics simulations were performed by building 2D 
structures of the dendrimers in ChemBioDraw Ultra 11.0 (ChemBioOffice 2008), converted to 
3D ChemBio3D 11.0 (ChemBioOffice 2008), and saved as mol files. The mol files were 
submitted to 3D optimization in Avogadro 1.0 (http://avogadro.openmolecules.net) using MMFF 
force field[18] and saved in a pdb format. 
The resulting structures of all of the dendrimers studied were imported into Maestro version 9 
(www.schrodinger.com) and minimized with Macromodel version 9.7.211[19] for 2500 
iterations using OPLS2005 force field[20]. The effects of water as solvent were taken into 
account by Generalized Borhn/Surface Area (GB/SA) implicit solvent model[21]. The 
protonation state of the nitrogen atoms at branching points and of the carboxylic groups on the 
surface were confirmed by pKa calculations using sparc online version 4.5 
(http://sparc.chem.uga.edu/sparc/). Molecular dynamics simulations using same force field and 
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implicit solvent methods were performed at 300k with Macromodel. The extended cut-off 
distances were set at their default values for implicit solvation, namely Van der Waals (8.0 Å), 
electrostatic (20.0 Å), and H-bond interactions (4.0 Å). A 100 ps equilibration simulation was 
preceded by 2500 steps of minimization. A 2 ns production run was performed as previously 
described[22]. A sample structure was recorded for every 10 ps of the simulation for trajectory 
analysis. 
 
In addition, 10 ns molecular dynamics simulations were performed with explicit solvent. The 
initial structures used for these simulations were the structures resulting from the previous 
simulations with implicit solvation. Desmond was used to perform molecular dynamics 
simulations with explicit solvent[23]. The dendrimer glucosamine system was built using the 
SPC solvation model and the size of the box determined automatically by creating a buffer zone 
of 10 Å around the dendrimer. The molecular dynamics simulation, structure minimization and 
relaxation steps were performed for 10 ns at 300 K and 1.03 bar. Snapshot structures were 
recorded every 5 ps. 
 
2.2. Molecular surface: 
The molecular surface of each structure was then calculated in trajectories by Maestro 9 using a 
1.4 Å probe, the values exported in cvs format, and the image of the surface area of each 
dendrimer under study exported as jpeg. Flexibility was assessed with RMSD trajectory analysis; 
the first 20 structures of each trajectory were discarded and the RMSD determined in relation to 
the first of the remaining structures using Maestro toolkit, and then exported in cvs format. The 
hydrophobic and hydrophilic surfaces were calculated for a single structure of each trajectory 
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using Maestro 9 with isovalues of 0.5 and -6 respectively. The images were exported as jpeg and 
the area values noted. The trajectories of each molecule were saved in mol2 format and imported 
into VegaZZ 2.2.0.54 [24] where the trajectory analysis tool was used for polar surface 
calculations along the trajectory with a probe radius of 1.4 Å. Microsoft Excel was used to plot 
all properties determined. 
2.3. Hybrid dendrimer chemistry: 
A narrow polydispersity (Mw / Mn), where Mw  is the weight average molar mass and Mn is the 
number average molar mass has been achieved for G1 and G2 PAMAM dendrimers;  (a) the G1-
amine had a Mn of 1,430 g/mol and a polydispersity of 1.024;  (b) the G1-acid had a Mn of 2,230 
g/mol and a polydispersity of 1.070;  (c) the G2-amine had a Mn of 3,256 g/mol and a 
polydispersity of 1.054. In addition, reverse-phase HPLC has been successfully used to purify 
G1 and G2 PAMAM dendrimers from crude reaction products[25]. Taken together, these 
analytical observations encouraged us to pursue the synthesis of a partially glycosylated hybrid 
triazine PAMAM dendrimer. 
The synthesis and analytical characterization of dendrimer 6 has been reported[14]. A solution of 
6 was prepared by dissolving 8.49 g (1.692 mmol) in 50 ml methanol.  The flask was immersed 
in a water bath at room temperature.  To the dendrimer solution, 150 ml (134.7g, 2.24 mol) of 
ethylenediamine (EDA) corresponding to 55 mole equivalents of EDA per mole of ester was 
slowly added, under continuous stirring, to avoid the rapid release of significant amounts of heat.  
The reaction mixture was allowed to stir at room temperature.  Aliquots were taken to which 
diethyl ether was added, resulting in the precipitation of the dendrimer.  The sample was 
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subjected to centrifugation and the collected solid analyzed by MALDI-TOF-MS.  Additional 
EDA was added into the reaction when no change was observed between MS traces.  When the 
reaction was complete, methanol and excess EDA were removed by adding the reaction mixture 
to a flask containing diethyl ether under continuous stirring.  Gummy solids were produced 
which were allowed to settle overnight followed by removal of EDA, methanol and diethyl ether 
mixture by decantation. 
1
H NMR (CDCl3): δ 4.0-3.55 (br, m), 3.55-3.1 (br, m), 3.1-2.58 (br, m),
2.56-2.17 (br, m), 2.03-1.23 (br, m). 
13
C NMR (CDCl3): δ 174.41, 164.41, 72.50, 65.91, 64.39,
48.66, 44.21, 40.31, 39.72, 39.62, 32.61, 14.10.    
A solution was then prepared by dissolving the oily amine terminated triazine PAMAM hybrid 
dendrimer 7 obtained from the previous reaction (corresponding to 9.63 g, 1.692 mmol) in 50 
mL methanol.  Methyl acrylate was slowly added to this solution.  Initially, 7.31 ml (6.98 g, 
81.22 mmol) of methyl acrylate (corresponding to 10 mole equivalents per NH2) was added.  The 
reaction mixture was allowed to stir at room temperature.  Samples were taken over time and 
analyzed by MALDI-TOF-MS.  Additional methyl acrylate was added to the reaction until no 
further change was observed between the MS traces.  The reaction was deemed complete after a 
total of 40 mole equivalents of methyl acrylate per NH2 had been added, and the reaction 
allowed to react for 11 days.  Methanol and excess methyl acrylate were removed under reduced 
pressure to yield an oily substance. 
1
H NMR (CDCl3): δ 4.07-3.47 (br, m), 3.59 (s), 3.35(s), 3.29-
3.09 (br, m), 3.03 (br, m), 2.84 (br, m), 2.80-2.60 (br, m), 2.56 (br, m), 2.52-2.10 (br, m), 1.89 
(m), 1.84-1.60 (br, m), 1.60-1.26 (br, m). 
13
C NMR (CDCl3): δ 173.02, 165.39, 51.55, 49.06,
45.16, 44.11, 43.10, 32.35, 30.31, 25.79. 
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The oily dendrimer 8, obtained from the previous reaction, was dissolved in methanol and an 
aliquot of the solution corresponding to 1.0 g of dendrimer 8 taken.  The solvent was removed 
under reduced pressure and the remaining material dissolved in 10 ml of 2 M NaOH. It was then 
allowed to react at room temperature.  Progress of the hydrolysis reaction was monitored using 
FT-IR and MALDI-TOF-MS.  The NIR spectra showed the disappearance of the signal 
corresponding to the carbonyl of the ester group, and the appearance of a signal corresponding to 
the carbonyl of the acid group; the signal corresponding to the amide carbonyl remained constant 
(Supplementary Figure 1).  Complete hydrolysis of the esters was observed after 2 days.  The 
mixture was acidified to pH 3 using 2 M HCl.  The acidified solution was then filtered in two 
stages using Amicon ultrafiltration stirred cells (Amicon Bioseparations) under nitrogen 
pressure.  The first stage required a cell with a preconditioned regenerated cellulose membrane 
filter with a MWt cut-off of 10 kDa.  The collected filtrate was transferred into another Amicon 
ultrafiltration stirred cell with a similar membrane but with a MWt weight cut-off of 1 kDa.  The 
retained solution was collected and the solvent removed under reduced pressure to yield a 
yellowish solid. The removal of excess acrylate was observed in the NIR spectra as the decrease 
in the acid carbonyl signal relative to the signal for the amide carbonyl. 
1
H NMR (D2O): δ 3.75-
2.90 (br, m), 2.85-2.20 (br, m), 2.15-1.10 (br, m). 
13
C NMR (D2O): δ 177.40, 171.97, 51.43,
50.97, 50.62, 49.31, 47.70, 34.38, 30.42, 30.10. 
2.4. Partially glycosylated hybrid dendrimer chemistry: 
The dendrimer 9 (100 mg, 10.9 µmoles) was dissolved in 1 ml of endotoxin free water and added 
to 100 mg (0.465 mol) of glucosamine-HCl dissolved in 2 ml of water (pH 5.0). 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDCI) (260 mg, 1.356 mmol) was dissolved 
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in 5.2 ml water (pH 5.0) and added to 9 and glucosamine, and stirred for 3 h at room temperature 
at pH 5. The solution was then filtered through a Pierce Concentrator with MWt cut-off of 20 
kDa and transferred into an Amicon ultrafiltration stirred cell with a MWt cut-off of 2 kDa. The 
dialysate was lyophilized and reconstituted in water at 50 mg/ml.  
1
H NMR (D2O): δ 5.28 (d), 
5.06 (br, s), 3.78-2.80 (br, m), 2.78-2.1 (br, m), 2.05-1.82 (br, m), 1.81-1.65 (m), 1.60-1.10 (br, 
m), 1.09-0.96 (br, t), 0.95-0.75 (t). 
13
C NMR (D2O): δ 177.20, 171.86, 104.71, 94.86, 90.74,
89.07, 75.86, 73.75, 71.48, 70.63, 70.03, 60.64, 60.46, 55.25, 53.94, 42.67, 42.57, 36.30, 34.86, 
24.92, 14.30. 
2.5. Analytical chemistry: 
1
H and 
13
C NMR of the samples in D2O were obtained using a Varian Mercury 300 MHz
instrument with the NMR spectra of 2 acquired using a Bruker Avance 500 MHz instrument.  
Chemical shifts are reported in parts per million on the δ scale relative to solvent. MALDI-TOF 
mass spectra were obtained using an ABI Voyager-DE STR mass spectrometer operating in 
reflected mode using 2,4,6-trihydroxyacetophenone (THAP) as the matrix. When needed, MS 
and FT-IR data were reprocessed using Origin8 and Microsoft Excel software packages. Solution 
infrared spectra were recorded on a Bruker Tensor 27 FTIR spectrometer using 0.1 mm NaCl 
sealed cells. IR spectroscopy was useful for monitoring the hydrolysis of the methyl ester; the 
disappearance of this band confirmed our interpretation of the NMR. 
2.6. TLR4-MD-2-LPS responses: 
Peripheral blood mononuclear cells (PBMCs) were prepared by Ficoll‐Hypaque (GEHealthCare) 
density gradient centrifugation from human buffy coat residues. Purified PBMCs were allowed 
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to adhere to 15 cm sterile tissue culture plates for 1 h and then washed with PBS twice to remove 
non‐adherent cells. Adherent monocytes were removed with a cell scraper and counted using a 
Coulter counter.  
 
Cytotoxicity was determined using MTT assays. Triplicate 200 μl samples of culture media 
(RPMI 1640 + 10% FCS) containing 10
5
 monocytes and serial dilutions of the molecules (25 – 
600 μg/ml) were incubated for 7 h at 37ºC in 96 well tissue culture plates. Fifty μl of MTT 
(Invitrogen, 5 mg/ml in PBS) was then added and the incubation continued for 2 h. The positive 
control had no molecule added, and the negative control had 0.5% Triton X‐100 to ensure cell 
death. Optical density was read at 490 nm and percentage survival calculated. 
 
TLR4 induced inflammation was studied by culturing one million monocytes in 1 ml of culture 
media for 1 h in 48 well tissue culture plates to enable cell adherence. The molecules (25 – 400 
μg/ml) were then added in duplicate to wells for 30 min followed by 25 ng/ml of ultra‐pure LPS 
(Salmonella minnesota, Invivogen). Positive control wells contained LPS only. Negative control 
wells contained monocytes only. After a 3 h incubation, the media was removed and the cells 
lysed in 500 μl Tri‐Reagent (Sigma).  
 
RNA was then extracted and reverse transcription performed on 400 ng of RNA using a Qiagen 
kit. Triplicate aliquots of the cDNA were subjected to quantitative real time PCR for HPRT, 
MIP‐1β[CCL4], IL‐8, TNF‐α, IL‐6, IL‐10 and IFN‐β as previously described[6] using a Corbett 
Rotorgene 3000 PCR machine and a JumpStart Sybr Green mix (Sigma). Results were expressed 
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as the log10 absolute copy number for each chemokine and cytokine mRNA per 10
5
 copies of
HPRT (a house keeping gene) mRNA. The results shown are from three experiments. 
3. Results:
3.1. Computational design parameters: 
We first focused on replacing the core of the PAMAM dendrimer with a hybrid triazine-
PAMAM dendrimer that was derived from the extension of a reported strategy[14]. Our design 
criteria were shaped by three key parameters. First, the hydrophobic triazine core would have to 
be “hidden” with groups that conveyed water solubility and a hydrophilic surface to the hybrid 
dendrimer, and which also enabled the outward facing presentation of the monosaccharide via a 
carboxylic acid reaction site. Second, the use of a discrete, higher generation polyamine core 
(i.e., a triazine dendrimer) would reduce substantially the structural heterogeneity of the final 
hybrid dendrimer. Third, the use of PAMAM chemistry had to be reduced to a minimum because 
it increases structural heterogeneity[14,15]. 
To compare the molecular properties of biologically active 1 with those of several triazine based 
dendrimers that were biologically inactive, we used molecular modelling techniques and an 
established protocol[22] with which we have previously had considerable success for both 
proteins and peptides[22,26-28]. The glycosylated PAMAM, triazine, and several variations of 
the generations of the hybrid triazine and PAMAM dendrimers, were simulated with implicit 
solvation. Deriving useful data from these modelling studies required the assumption that the 
representative structure 1 could effectively communicate key design principles using which 
structures could be modelled and compared. MS and NMR analysis of 1 showed an average of 8 
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glucosamines per PAMAM dendrimer molecule[6]; i.e., 2 glucosamine residues on each of the 4 
arms of 16 carboxylics each of the G3.5 PAMAM model of 1 (Scheme 1).  
 
This was confirmed by a combination of quantum chemistry calculations and molecular 
dynamics simulations of a series of dendrimers with different glucosamine loadings[17]. The 
triazine based dendrimers were then built with a total of 6 glucosamines; i.e., 2 glucosamines on 
each of the 3 arms of the triazine analogues because this was sterically and energetically the most 
favourable configuration. The position of the glucosamine molecules on each branch was 
randomly assigned because molecular dynamics simulation studies showed that the carboxylic 
acid groups were both equivalent and highly flexible[17]. In this paper, we present the detailed 
data for the representative hybrid dendrimers 2, 3, 4 (Scheme 1) because they were selected for 
chemical synthesis and biological evaluation. 
 
3.2. Molecular dynamics simulations: 
A set of 2 ns molecular dynamics simulations on each of these molecules and subsequent 
analysis revealed molecular properties that could impact on their bioactivity. We found that their 
surface properties did not vary significantly once the structures had equilibrated. As expected, 
their surface area (SA) varied considerably. The SA’s of 3 and 4 were much lower than those of 
1 and 2; they had a SA that was much closer to that of the target, 1 (Table 1). Molecular 
representation of the SA also showed a significant difference in the shapes of these molecules. 
While 3 and 4 presented a compact structure with the PAMAM branch units folding inwards, 2 
presented a relaxed structure with the PAMAM branch units facing outwards; this resulted in 
surface properties that were similar to those of the target, 1. Measurement of polar surface area 
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(PSA) mirrored this trend with 3 and 4 displaying a 4-fold smaller PSA than the target, 1.   The 
PSA of 2 was closest to that of the target, 1 (Table 1). Therefore, the SA, PSA, and the more 
relaxed structure (i.e., with branches outstretched) of the partially glycosylated G2 triazine G1.5 
PAMAM hybrid dendrimer was closest to the biologically active G3.5 PAMAM dendrimer 
glucosamine. This gave us the first indication of the relationship between the hydrophobic and 
hydrophilic surfaces of these molecules, and their impact on the design of bioactive hybrid 
dendrimers. 
3.3. Hydrophobicity and hydrophilicity: 
Our recent studies on the interaction of partially glycosylated G3.5 PAMAM dendrimers with 
MD-2 showed that these molecules interact with residues lining the hydrophilic entrance of MD-
2’s hydrophobic pocket without forming intermolecular contacts with the hydrophobic pocket 
itself[11].  It was therefore important to investigate the relative distribution of the hydrophobic 
and hydrophilic surfaces of these molecules because this could become a key feature of the 
design of bioactive hybrid dendrimers.  The surface of target 1 was mainly hydrophilic (Figure 
3). Dendrimer 3 had multiple exposed hydrophobic surfaces that were a consequence of the 
PAMAM branching units folding inwards and exposing the hydrophobic triazine core. Since the 
dendrimer 3 was found to be biologically inactive, this led us to conclude that surface 
hydrophobicity was not an important property for the molecule’s activity against the TLR4-MD-
2-LPS complex. These contrasting surface properties of bioactive as compared to bioinactive 
dendrimers provided us with clues for the selection of candidate molecules for synthetic studies. 
In the case of 2, its hydrophilic surface distribution shielded the hydrophobic triazine core from 
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solvent and led to the molecule adopting a globular shape. This meant that the surface 
characteristics of 2 resembled 1 much more closely than either 3 or 4 (Figure 3). 
Taken together, these modeling studies results predicted that the addition of 1.5 generations of 
PAMAM to the single species G2 triazine core, 5, would enable the synthesis of the simplest and 
most narrowly dispersed hybrid molecule that would also be bioactive. Notably, the G2 triazine 
G1.5 PAMAM hybrid dendrimer glucosamine also had a globular structure, a feature absent in 
the G2 triazine dendrimer itself. 
3.4. Surface charge distribution: 
The surface charge distribution was also identified as an important factor for bioactivity[11]. The 
polar surface area values given above do not provide insights into the location of the polar 
surfaces. We found that the distribution of the interpolated charges on the surfaces of the 
partially glycosylated triazine dendrimer and the partially glycosylated G2 triazine G0.5 
PAMAM hybrid dendrimer were similar; most were neutral surfaces with small areas of well 
separated negative charges (Figure 4). In contrast, the distribution of the interpolated charges on 
the surface of the partially glycosylated G2 triazine G1.5 PAMAM hybrid dendrimer were 
similar to those of the partially glycosylated G3.5 PAMAM dendrimer, despite differences in 
their internal charge distribution. Their polar surfaces were also closer to the surface for both 
dendrimers; this increased the probability of multiple electrostatic interactions with the target 
protein. These surface charge property similarities provided another explanation for why the 
partially glycosylated G2 triazine G0.5 PAMAM hybrid dendrimer and the partially glycosylated 
triazine dendrimer were not biologically active. As the partially glycosylated G2 triazine G1.5 
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PAMAM hybrid dendrimer had surface properties that were similar to those of the partially 
glycosylated G3.5 PAMAM dendrimer, we concluded, that it should be bioactive. 
3.5. Other partially glycosylated hybrid dendrimers: 
Several other molecules were also studied including a partially glycosylated G3 triazine G0.5 
PAMAM hybrid dendrimer, and a partially glycosylated G3 triazine G1.5 PAMAM hybrid 
dendrimer. This analysis showed that they had a similar molecular surface, hydrophilic versus 
hydrophobic surface distribution, and interpolated charge surfaces (Supplementary Figure 2). 
Taken together, these additional molecular modeling studies predicted that 1.5 layers of surface 
PAMAM were required to mimic the biological activity of 1. This meant that the number of 
PAMAM generations required for a bioactive hybrid dendrimer could be more than halved. 
3.6. Hybrid dendrimer chemistry: 
Our synthetic efforts commenced with a single species G2 triazine dendrimer that was available 
at the  kilogram scale[13]. It presented 12 amines at the periphery.  The reaction scheme is 
shown in Scheme 2. It included the sequential addition of methylacrylate, ethylenediamine and 
methylacrylate, followed by hydrolysis to yield the penultimate intermediate in this strategy. 
Dendrimer 6 arises from Michael addition to triazine dendrimer, 5, and comprises two products 
as previously described; the major and desired material with 24 methyl acrylate groups, 6, and 
the minor product with 23 groups[14]. Hydrolysis of the hybrid material 8 was achieved with 2 
M NaOH.  Previously, 6 had been subjected to 6 M HCl for hydrolysis, but the presence of 
amide bonds in this material precluded that strategy.  High salt concentrations and the presence 
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of multiple carboxylate counterions (i.e., H
+
 or Na
+
) led to mass spectra that were unsuitable for
the purpose of monitoring reaction progress. 
3.7. Analytical chemistry: 
Characterization of these materials (6 to 9, and 2) reflected both the advantages conveyed by 
triazine chemistry and the challenges inherent in the synthesis of larger generation dendrimers 
using PAMAM chemistry[14,15]. The mass spectrometry revealed a faithful elaboration of the 
starting material; those intermediates bearing excess graft that could arise from either residual 
diamine or retro-Michael reactions could be much more readily assigned than for the G3.5 
PAMAM dendrimer with which we had originally started our studies. This meant that there was 
a better understanding of the heterogeneity that arose from the PAMAM portion of this hybrid 
molecule. 
The unambiguous assignment of the 
1
H NMR spectra was precluded by the presence of several
broad and overlapping signals, and was in agreement with the previously reported spectra of 
hybrid dendrimers[15].  We were able to define the diagnostic features of: (i) groups associated 
with the triazine core[13]; (ii) groups associated with the PAMAM layer[6]; (iii) the 
glucosamines[6]. The glucosamines provided useful lines for the H1 proton in either alpha (5.28 
ppm) or beta (5.06 ppm) configurations in a region that is distinct from the dendrimer portions 
downfield. The rest of the glucosamine signals are found between 3 and 4 ppm and they 
overlapped with CH2 groups from the dendrimer (2.5 to 4 ppm) itself. The other downfield 
signatures observed could be subdivided into regions associated with the triazine dendrimer 
itself, including CH2 groups, that are adjacent to an exocyclic N-triazine (4.1-3.5 ppm), and those 
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of the piperidine groups (2.0-1.2 ppm).  Urea obscures this latter region with CH2 groups 
appearing from 2.05 - 1.80 ppm, and a characteristic methyl group at 1.1 - 0.9 ppm.  The need 
for relative integrations of the CH2 groups that are associated with PAMAM derived from 
acrylate groups, either next to the nitrogen (3.3 - 3.1 ppm) or the carbonyl (2.8 - 2.2 ppm) was 
reduced, given our ability to monitor these reactions with mass spectrometry. Taken together, 
these results showed that 8 glucosamines were present on the surface of the desired product 2. 
3.8. Biological studies: 
The products were evaluated using an MTT assay to determine their relative cellular toxicity. 
Neither 1 nor 2 was toxic to primary human blood derived monocytes at 600 μg/ml after a 7 h 
incubation, a time point chosen because the half‐life of 1 in blood was 7 h (Supplementary 
Figure 3). When endotoxin free 2 was compared with 1, it was found to be an equally effective 
partial antagonist of TLR4-MD-2-LPS complex induced pro-inflammatory cytokine production 
(Figure 5). At 100 μg/ml, the mRNA copy number of IL‐6 was reduced by 2.2 log10 (99.3%), 
Macrophage Inflammatory Protein (MIP) ‐1β[CCL4] by 1.7 log10 (98%), Tumor Necrosis 
Factor‐α (TNF‐α) by 1.1 log10 (96%), and Interleukin (IL) ‐8 by 1.6 log10 (91%) when compared 
to the maximal stimulation of pro-inflammatory chemokines and cytokines that was triggered 
with 25 ng/ml of ultra‐pure LPS. The ED50 of these two molecules was similar at 75 ± 15 μg/ml. 
Neither 1 nor 2 affected production of the anti-inflammatory cytokines Interleukin-10 and 
Interferon-γ. 
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3.9. Validation of computational design principles: 
We have previously shown, for partially glycosylated G3.5 PAMAM dendrimers, that there are 
no significant differences in the surface properties of the partially glycosylated molecules 7, 8 
and 9 [17]. We therefore did not expect differences between the hybrid 2, as modelled with 6 
surface glucosamines, and the experimentally synthesised hybrid molecule with 8 surface 
glucosamines. Nevertheless, to validate our molecular modelling principles, and to confirm the 
accuracy of the properties that we had predicted from our modelling studies, we performed an 
additional 2 ns molecular dynamics simulation to determine the properties for the hybrid 2 (with 
8 glucosamines) as  compared to the hybrid 2 (with 6 glucosamines). We found that there was no 
significant difference in the calculated values for either Surface Area (SA) = 8732 vs 8536 Å
2 
 or
Polar Surface Area (PSA) = 5807 vs 5776 Å
2
 for the hybrid 2 (with 8 glucosamines) when it was
compared to the hybrid 2 (with 6 glucosamines) respectively. 
In further studies, we went on to perform longer molecular dynamics simulations of these two 
hybrid molecules in explicit water to gain a better insight into their behaviour. Their surface 
properties were, once again, determined for each partially glycosylated dendrimer along the 
trajectory (Table 2). The surface area (SA) and polar surface area (PSA) showed an increase 
when comparing the triazine dendrimer with the G2 triazine G1.5 PAMAM hybrid dendrimer. In 
addition, these results also showed that there was no significant difference between the hybrid 
dendrimer with 6 surface glucosamines that was predicted to be bioactive, and the model 
generated of the experimentally synthesized and bioactive hybrid dendrimer with 8 surface 
glucosamines. The gyration radius values determined also showed the same trend; the G2 
triazine G1.5 PAMAM hybrid dendrimer was a less compact structure. Notably 2(with 6 
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glucosamines) and 2(with 8 glucosamines) were very similar to the biologically active PAMAM 
dendrimer, 1. 
3.10. Explicit versus implicit solvent: 
The results of longer simulations in explicit solvent were consistent with the results from implicit 
solvent studies for bioactive molecules. This demonstrated that the implicit solvent approach, 
even though it implies more approximations, can be usefully adopted as an efficient and time 
effective approach to aid the design of dendrimer constructs. It should be noted that our 
experience also suggests that, for a better understanding of the interactions of these molecules 
with their biological target, it is prudent to undertake longer simulations in explicit solvent[11]. 
4. Discussion:
We describe a rational computational modelling based approach to the design of molecules with 
pre-defined bioactivity, and their subsequent synthesis, characterization and biological 
evaluation. Our studies show that bioactive molecules share several surface properties that 
required the addition of 1.5 generations of PAMAM to the core dendrimer. This more than 
halves the previously reported PAMAM requirement for a partially glycosylated dendrimer[6]. 
We now propose that the molecular modelling design principles described could be used to 
identify other structurally optimised dendrimers with interesting bioactivity. Designing and 
delivering these molecules with MWts of 2 - 4 kDa, which we call synthetic baby-bios (SBBs), is 
the next challenge in this field of biomaterials. 
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5. Conclusion:
Computation played a central role in identifying alternative compositions of matter with the 
requisite hydrophilic surface areas, cluster density, flexibility and surface charge distribution 
required for bioactivity. The approach described should be applicable to the design and synthesis 
of other bioactive dendrimers for other pathogen related TLR receptors, such as TLR2 [29] and 
TLR3 [30], using alternative polypropyleneimine, polylysine or polypropyletherimine based 
chemistries. These SBBs could be useful for treating infectious, inflammatory and malignant 
diseases. 
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Captions: 
Scheme 1: 
Partially glycosylated dendrimers 1 – 4. 
Scheme 2: 
Synthesis of the partially glycosylated triazine PAMAM hybrid dendrimer. 
Figure 1:  
Illustration of the competition between LPS (agonist) and the partially glycosylated dendrimer (antagonist) for TLR4-
MD-2-LPS complex induced pro-inflammatory cytokine production. 
Figure 2a & b: 
Frontal view of the hydrophilic and hydrophobic surfaces of MD-2: 
The hydrophilic (cyan) surface of MD-2 defines the need for any new dendrimer based construct to also have a 
hydrophilic surface. In contrast, the hydrophobic (orange) area, to which the acyl chains of Lipid A bind, lies buried 
deep inside MD-2’s cavity. 
Figure 3: 
Hydrophilic (cyan) and hydrophobic (orange) surfaces of the partially glycosylated dendrimers 1 – 4. 
Figure 4: 
Surface charge:  
The red areas correspond to negatively charged residues and the blue areas to positively charged residues. 
(A) G2 triazine dendrimer modified with 6 glucosamine molecules. 
(B) G2 triazine G0.5 PAMAM hybrid dendrimer modified with 6 glucosamine molecules. 
(C) G2 triazine G1.5 PAMAM hybrid dendrimer modified with 6 glucosamine molecules. 
(D) G3.5 PAMAM dendrimer modified with 8 glucosamine molecules. 
Figure 5:  
Partial antagonist activity of 2 against the TLR4-MD-2-LPS cell surface receptor complex:  
The partially glycosylated hybrid dendrimer 2 blocked LPS triggered pro‐inflammatory chemokine (MIP-1β[CCL4] and 
IL-8) and cytokine (TNF-α and IL-6) production. It did not affect anti-inflammatory cytokine (IL-10 and IFN-β)
production. The control was cultured primary human monocytes. * = p<0.001 when compared to the LPS positive 
control (Student’s t‐test). n = 3. 
Table 1: 
Dendrimer surface property analysis along the trajectory of a 2 ns molecular dynamics simulation with implicit solvent. 
Table 2: 
Average molecular properties along the trajectory of 10 ns molecular dynamics simulation of the fully equilibrated 
molecules in explicit solvent. 
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Table 1: 
Dendrimer surface property analysis along the trajectory of a 2 ns molecular dynamics 
simulation with implicit solvent. 
3 4 2 1 
SA (Å
2
) 3570 3800 8536 11212 
PSA (Å
2
) 2035 2278 5776 7283 
Table 1
Table 2: 
Average molecular properties along the trajectory of 10 ns molecular dynamics simulation of the 
fully equilibrated molecules in explicit solvent. 
3 4 2(6g) 2(8g) 1 
SA (Å) 4527.93 5714.03 10648.88 10555.73 14181.90 
PSA (Å) 1793.17 2305.07 5030.59 4960.91 5782.19 
Gyration 
radius (Å) 11.61 13.58 17.96 17.65 19.38 
2(6g) – with 6 glucosamines; 2(8g) – with 8 glucosamines. 
Table 2
Supplementary Figure 1 
-0.1
0.4
0.9
1.4
1.9
1500160017001800
FT-IR spectra for the unpurified dendrimer 8 (blue trace), unpurified dendrimer 9 (green trace), and 
purified dendrimer 9 (purple trace). The spectra show the disappearance of the signal corresponding to the 
carbonyl of the ester group and the appearance of a signal corresponding to the carbonyl of the acid 
group, while the signal corresponding to the amide carbonyl remains constant.  Further, after purification, 
the removal of excess acrylate is observed with the decrease in the acid carbonyl signal relative to the 
signal for the amide carbonyl. 
Supplementary Figure 1
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Supplementary Figure 2 
  (A)    (B)      (C) 
Figure S2 (i): Molecular surface of:  
(A) G3 triazine G0.5 PAMAM hybrid dendrimer with 6 glucosamines. 
(B) G3 triazine G1.5 PAMAM hybrid dendrimer with 6 glucosamines. 
(C) G3.5 PAMAM dendrimer with 8 glucosamines. The molecules are not to scale. 
Their average dendrimer surface properties along the trajectory of a 2 ns molecular dynamics simulation with implicit solvent are given below. 
Surface Area (Å
2
)  Polar Surface Area (Å
2
) 
G3 triazine G0.5 PAMAM hybrid dendrimer with 6 glucosamines  (A) 8,594 4,001 
G3 triazine G1.5 PAMAM hybrid dendrimer with 6 glucosamines  (B) 15,122 8,018 
Supplementary Figure 2
2 
 (A)     (B)  (C)    (D) 
Figure S2 (ii): The overall distribution of the hydrophilic (blue) and hydrophobic (brown) surfaces was identified as a key determinant for 
bioactivity. These are shown for the following molecules:- 
(A) G3 triazine dendrimer with one glucosamine. 
(B) G3 triazine G0.5 PAMAM hybrid dendrimer with 6 glucosamines. 
(C) G3 triazine G1.5 PAMAM hybrid dendrimer with 6 glucosamines. 
(D) G3.5 PAMAM dendrimer with 8 glucosamines. 
Taken together, these graphical representations show that the partially glycosylated G0.5 PAMAM hybrid dendrimer (B) follows the same trend as 
the minimally glycosylated triazine dendrimer (A) in that they both have large and exposed hydrophobic surfaces. In contrast, the partially 
glycosylated G1.5 PAMAM hybrid dendrimer (C) has its internal hydrophobic area almost fully contained by the PAMAM surface giving this 
molecule a large hydrophilic surface. As such, it most closely resembles the partially glycosylated G3.5 PAMAM dendrimer (D). 
3 
      (A)      (B)  (C)     (D) 
Figure S2 (iii): 
Charge surfaces for:-  
(A) G3 triazine dendrimer with one glucosamine. 
(B) G3 triazine G0.5 PAMAM hybrid dendrimer with 6 glucosamines. 
(C) G3 triazine G1.5 PAMAM hybrid dendrimer with 6 glucosamines. 
(D) G3.5 PAMAM dendrimer with 8 glucosamines. 
The red areas correspond to negatively charged residues and the blue areas to positively charged surfaces. 
The dendrimer’s charge surface distribution was also identified as an important factor for bioactivity. The charge surfaces showed a similar 
compactness for the minimally glycosylated triazine dendrimer (A) and the partially glycosylated G0.5 PAMAM hybrid dendrimer (B). The 
compactness of the partially glycosylated G1.5 PAMAM hybrid dendrimer (C) was similar to that of the partially glycosylated G3.5 PAMAM 
dendrimer (D). 
Supplementary Figure 3: 
 
Peripheral blood mononuclear cells (PBMCs) were prepared by Ficoll-Hypaque (GE-HealthCare) density 
gradient centrifugation from human buffy coat residues. Purified PBMCs were allowed to adhere to 15 
cm sterile tissue culture plates for 1 h and then washed with PBS (twice) to remove non-adherent cells. 
Adherent monocytes were removed with a cell scraper and counted using a Coulter counter.  
Cytotoxicity was determined using an MTT assay. Triplicate 200 µl samples of culture media (RPMI 
1640 + 10% FCS) containing 10
5
 monocytes and serial dilutions of the molecules (25 – 600 µg/ml) were 
incubated for 7 h at 37
0
C in 96 well tissue culture plates. Fifty µl of MTT (Invitrogen, 5 mg/ml in PBS) 
was then added and incubated for 2 h. The positive control had no molecule added and the negative 
control had 0.5% Triton X-100 to ensure cell death. Optical density was read at 490 nm and percentage 
cell survival calculated. 
Partially glycosylated G2 triazine 1.5G PAMAM
hybrid dendrimer after a 7 h incubation
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